Biogen Inc. (BIIB)
NASDAQ: BIIB · Real-Time Price · USD
207.94
+1.66 (0.80%)
Aug 7, 2026, 4:00 PM EDT - Market closed
Biogen Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 30,724 | 25,818 | 22,296 | 37,496 | 39,904 | 35,268 | |
Market Cap Growth | 57.69% | 15.80% | -40.54% | -6.04% | 13.15% | -5.49% |
Enterprise Value | 37,794 | 28,579 | 26,551 | 43,784 | 41,616 | 39,133 |
Last Close Price | 207.94 | 175.99 | 152.92 | 258.77 | 276.92 | 239.92 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 36.88 | 20.02 | 13.68 | 32.47 | 13.27 | 23.07 |
Forward PE | 15.67 | 13.66 | 9.71 | 17.54 | 17.70 | 13.94 |
PEG Ratio | 6.06 | 4.75 | 1.90 | 4.38 | 17.68 | 39.30 |
PS Ratio | 3.06 | 2.61 | 2.30 | 3.81 | 3.92 | 3.21 |
PB Ratio | 1.63 | 1.41 | 1.33 | 2.53 | 2.98 | 3.24 |
P/TBV Ratio | - | 10.01 | 40.87 | 173.47 | 6.97 | 12.32 |
P/FCF Ratio | 11.39 | 12.59 | 8.19 | 29.52 | 34.88 | 10.43 |
P/OCF Ratio | 10.67 | 11.71 | 7.75 | 24.23 | 28.83 | 9.69 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 3.77 | 2.89 | 2.74 | 4.45 | 4.09 | 3.56 |
EV/EBITDA Ratio | 17.44 | 10.68 | 9.00 | 20.78 | 10.97 | 11.94 |
EV/EBIT Ratio | 28.53 | 15.08 | 11.66 | 27.16 | 12.71 | 14.03 |
EV/FCF Ratio | 14.02 | 13.94 | 9.75 | 34.47 | 36.38 | 11.57 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.40 | 0.36 | 0.29 | 0.49 | 0.49 | 0.60 |
Debt / EBITDA Ratio | 3.85 | 2.46 | 2.25 | 3.48 | 1.74 | 2.32 |
Debt / FCF Ratio | 3.10 | 3.21 | 2.44 | 5.78 | 5.78 | 2.25 |
Net Debt / Equity Ratio | 0.38 | 0.15 | 0.26 | 0.43 | 0.13 | 0.35 |
Net Debt / EBITDA Ratio | 3.26 | 1.03 | 1.44 | 2.98 | 0.45 | 1.16 |
Net Debt / FCF Ratio | 2.62 | 1.35 | 1.56 | 4.95 | 1.51 | 1.12 |
Asset Turnover | 0.33 | 0.34 | 0.35 | 0.38 | 0.42 | 0.45 |
Inventory Turnover | 1.15 | 1.04 | 0.93 | 1.31 | 1.69 | 1.74 |
Quick Ratio | 0.94 | 1.70 | 0.77 | 0.92 | 2.15 | 1.34 |
Current Ratio | 1.87 | 2.68 | 1.35 | 2.00 | 2.99 | 1.83 |
Return on Equity (ROE) | 4.50% | 7.39% | 10.36% | 8.24% | 24.33% | 15.96% |
Return on Assets (ROA) | 3.55% | 5.48% | 7.11% | 5.62% | 11.14% | 11.16% |
Return on Invested Capital (ROIC) | 4.71% | 7.50% | 9.27% | 7.98% | 18.06% | 17.65% |
Return on Capital Employed (ROCE) | 4.88% | 7.80% | 9.92% | 7.22% | 16.03% | 13.79% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 2.72% | 4.99% | 7.31% | 3.08% | 7.54% | 4.33% |
FCF Yield | 8.78% | 7.94% | 12.21% | 3.39% | 2.87% | 9.59% |
Buyback Yield / Dilution | -1.20% | -0.82% | -0.21% | 0.27% | 2.41% | 7.25% |
Total Shareholder Return | -1.20% | -0.82% | -0.21% | 0.27% | 2.41% | 7.25% |